Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis
DOI:
https://doi.org/10.2340/actadv.v104.12623Keywords:
Betamethasone dipropionate, Calcipotriol, DLQI, Matching-adjusted indirect comparison, Psoriasis, Quality of lifeAbstract
Abstract is missing (Short communication)
Downloads
References
Rudnicka L, Olszewska M, Goldust M, Waśkiel-Burnat A, Warszawik-Hendzel O, Dorożyński P, et al. Efficacy and safety of different formulations of calcipotriol/betamethasone dipropionate in psoriasis: gel, foam, and ointment. J Clin Med 2021; 10: 5589.
https://doi.org/10.3390/jcm10235589 DOI: https://doi.org/10.3390/jcm10235589
Paul C, Stein Gold L, Cambazard F, Kalb RE, Lowson D, Bang B, Griffiths CEM. Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study. J Eur Acad Dermatol Venereol 2017; 31: 119-126.
https://doi.org/10.1111/jdv.13859 DOI: https://doi.org/10.1111/jdv.13859
Koo J, Tyring S, Werschler WP, Bruce S, Olesen M, Villumsen J, Bagel J. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris - a randomized phase II study. J Dermatol Treat 2016; 27: 120-127.
https://doi.org/10.3109/09546634.2015.1083935 DOI: https://doi.org/10.3109/09546634.2015.1083935
Pinter A, Green LJ, Selmer J, Praestegaard M, Gold LS, Augustin M. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. J Eur Acad Dermatol Venereol 2022; 36: 228-236.
https://doi.org/10.1111/jdv.17734 DOI: https://doi.org/10.1111/jdv.17734
tein Gold L, Green LJ, Dhawan S, Vestbjerg B, Praestegaard M, Selmer J. A phase 3, randomized trial demonstrating the improved efficacy and patient acceptability of fixed dose calcipotriene and betamethasone dipropionate cream. J Drugs Dermatol 2021; 20: 420-425.
https://doi.org/10.36849/JDD.5653 DOI: https://doi.org/10.36849/JDD.5653
app KA, Thoning H, Gerdes S, Megna M, Brandi H, Jablonski Bernasconi MY, Yélamos O. Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis. J Dermatolog Treat 2022; 33: 3005-3013.
https://doi.org/10.1080/09546634.2022.2095330 DOI: https://doi.org/10.1080/09546634.2022.2095330
eich A, Selmer J, Galván J, Trebbien P, Pi-Blanque A, Danø A, et al. Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasis. Curr Med Res Opin 2022; 38: 1521-1529.
https://doi.org/10.1080/03007995.2022.2078099 DOI: https://doi.org/10.1080/03007995.2022.2078099
Griffiths CE, Stein Gold L, Cambazard F, Kalb RE, Lowson D, Møller A, Paul C. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. Eur J Dermatol 2018; 28: 356-363.
https://doi.org/10.1684/ejd.2018.3302 DOI: https://doi.org/10.1684/ejd.2018.3302
Hong CH, Papp KA, Lophaven KW, Skallerup P, Philipp S. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study. J Eur Acad Dermatol Venereol 2017; 31: 1876-1883.
https://doi.org/10.1111/jdv.14515 DOI: https://doi.org/10.1111/jdv.14515
Signorovitch JE, Sikirica V, Erder MH, Xie J, Lu M, Hodgkins PS, et al. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research. Value Health 2012; 15: 940-947.
https://doi.org/10.1016/j.jval.2012.05.004 DOI: https://doi.org/10.1016/j.jval.2012.05.004
Bewley A, Barker E, Baker H, Green W, Avey B, Pi-Blanque A, et al. An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis. J Dermatol Treat 2022; 33: 3191-3198.
https://doi.org/10.1080/09546634.2022.2116924 DOI: https://doi.org/10.1080/09546634.2022.2116924
Feldman SR, Præstegaard M, Andreasen AH, Selmer J, Holm-Larsen T. Validation of the self-reported Psoriasis Treatment Convenience Scale (PTCS). Dermatol Ther (Heidelb) 2021; 11: 2077-2088.
https://doi.org/10.1007/s13555-021-00626-5 DOI: https://doi.org/10.1007/s13555-021-00626-5
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Ahmad Jalili, Henrik Thoning, Marie Y. Jablonski Bernasconi, Kim Papp
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
